Top Updates Back
Modalis Therapeutics Corporation
株式会社モダリス
Modalis Inc. Alias
2018-04-01
4883
TYO
Japan
Gene therapy
CRISPR genome editing
Epigenome editing
CRISPR-GNDM®
Tokyo, Japan
Haruhiko Morita
100,000,000
4 people
50 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Modalis Therapeutics Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

32 entries
DateDescription
2016-01 Founded EdiGENE Corporation (now Modalis Therapeutics Corporation)
2016-01 Jan 2016 EdiGene Corporation founded
2016-01 EdiGene Corporation founded
2016-04 Established our subsidiary EdiGENE Inc. (now Modalis Therapeutics Inc.) in Cambridge, Massachusetts, USA
2016-04 Apr 2016 Established fully owned US subsidiary, EdiGENE Inc. (Now Modalis Therapeutics Inc.)
2016-04 Established fully owned US subsidiary, EdiGENE Inc. (Now Modalis Therapeutics Inc.)
2017-04 Initial research collaboration formed with Astellas Pharma Inc.
2017-09 Entered into an exclusive license agreement with the University of Tokyo regarding CRISPR technology
2017-09 Sep 2017 Initial research collaboration formed with Astellas Pharma Inc.
2017-09 Obtained license on engineered Cas9 technology from University of Tokyo
2019-02 Feb 2019 Obtained license on engineered Cas9 technology from University of Tokyo
2019-02 Established a license agreement on a genetic disorder with Astellas Pharma Inc.
2019-03 The U.S. subsidiary relocated and expanded within Cambridge
2019-03 Mar 2019 Established a license agreement on a genetic disorder with Astellas Pharma Inc.
2019-03 US subsidiary relocated to the new facility
2019-08 Changed company name to Modalis Therapeutics Corporation
2019-08 Aug 2019 US subsidiary relocated to the new facility
2019-08 EdiGene renamed to Modalis Therapeutics
2019-09 Sep 2019 EdiGene renamed to Modalis Therapeutics
2019-09 Established 2nd license agreement for additional genetic disorder with Astellas Pharma Inc.
2019-11 Nov 2019 Established 2nd license agreement for additional genetic disorder with Astellas Pharma Inc.
2019-11 Collaboration agreement with Eisai Co., Ltd.
2020-04 Entered into a non-exclusive license agreement with Editas Medicine, Inc. for the implementation of CRISPR/Cas9 patents
2020-04 Apr 2020 Collaboration agreement with Eisai Co., Ltd.
2020-04 Modalis Obtains Access to Foundational CRISPR IP
2020-08 Listed on the Tokyo Stock Exchange Mothers market (ticker: 4883)
2020-08 Aug 2020 Modalis Obtains Access to Foundational CRISPR IP
2020-08 Listing on Mothers, Tokyo Stock Exchange (Ticker symbol: 4883)
2021 About Oct 2021 US subsidiary relocated to the new facility
2021-10 The U.S. subsidiary relocated and expanded within Waltham
2021-10 Oct 2021 Listing on Mothers, Tokyo Stock Exchange (Ticker symbol: 4883)
2021-10 US subsidiary relocated to the new facility
+ Loaded when opened
1010001172984
Trade name株式会社モダリス
Trade name (kana)モダリス
Name in EnglishModalis Therapeutics Corporation
Corporation type301
Address〒103-0023 東京都中央区日本橋本町３丁目１１番５号
Postal code1030023
Prefecture code13
City code102
Address outside Japan
Prefecture in EnglishTokyo
City in English3-11-5 Nihonbashi-Honcho, Chuo ku
Address outside Japan in English
Corporate number assignment date2016-01-20
Update date2025-05-26
Change date2020-09-14
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record1
Excluded from search0
Processing type12
Correction type1
Trade name image ID
Address image ID
Sequence number1279237
Source: National Tax Agency Corporate Number Publication Site, basic three items
1010001172984
Corporate number1010001172984
Trade name株式会社モダリス
Trade name (kana)モダリス
Trade name (alphabet)Modalis Therapeutics Corporation
Registry closure date
Reason for registry closure
Registered address東京都中央区日本橋本町３丁目１１番５号
Postal code1030023
Prefecture東京都
Prefecture code13
City or district中央区
City code102
Street address日本橋本町３丁目１１番５号
Organisation type301
Processing type12
Correction type1
Status
Representative代表取締役CEO　森田　晴彦
Capital1728097000
Employees3
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date2025-05-26
Key information1010001172984
Source: gBizINFO (Ministry of Economy, Trade and Industry)
✅
2026-09-21 18:59 (Model: gpt-4.1-nano )
↑